[Basiliximab in the treatment of acute steroid-resistant rejection after liver transplantation].
Alvarez Castro, Ana M
[Basiliximab in the treatment of acute steroid-resistant rejection after liver transplantation]. [electronic resource] - Gastroenterologia y hepatologia Nov 2012 - 649-51 p. digital
Publication Type: Case Reports; Journal Article
0210-5705
10.1016/j.gastrohep.2012.03.016 doi
Acute Disease
Antibodies, Monoclonal--therapeutic use
Basiliximab
Carcinoma, Hepatocellular--complications
Cyclosporine--therapeutic use
Drug Resistance
Graft Rejection--drug therapy
Humans
Immunosuppressive Agents--therapeutic use
Liver Cirrhosis, Alcoholic--complications
Liver Function Tests
Liver Neoplasms--complications
Liver Transplantation
Male
Methylprednisolone--pharmacology
Middle Aged
Mycophenolic Acid--analogs & derivatives
Pregnenediones--pharmacology
Receptors, Interleukin-2--antagonists & inhibitors
Recombinant Fusion Proteins--therapeutic use
Tacrolimus--therapeutic use
[Basiliximab in the treatment of acute steroid-resistant rejection after liver transplantation]. [electronic resource] - Gastroenterologia y hepatologia Nov 2012 - 649-51 p. digital
Publication Type: Case Reports; Journal Article
0210-5705
10.1016/j.gastrohep.2012.03.016 doi
Acute Disease
Antibodies, Monoclonal--therapeutic use
Basiliximab
Carcinoma, Hepatocellular--complications
Cyclosporine--therapeutic use
Drug Resistance
Graft Rejection--drug therapy
Humans
Immunosuppressive Agents--therapeutic use
Liver Cirrhosis, Alcoholic--complications
Liver Function Tests
Liver Neoplasms--complications
Liver Transplantation
Male
Methylprednisolone--pharmacology
Middle Aged
Mycophenolic Acid--analogs & derivatives
Pregnenediones--pharmacology
Receptors, Interleukin-2--antagonists & inhibitors
Recombinant Fusion Proteins--therapeutic use
Tacrolimus--therapeutic use